Rossi A, Olivares J
Laboratoire de Bioénergétique, Fondamentale et Appliquée, Université Joseph Fourier, Grenoble, France.
Cardiovasc Drugs Ther. 1998 Sep;12 Suppl 2:171-7. doi: 10.1023/a:1007752700936.
The metabolism of pyrimidine nucleotides in the myocardium is poorly understood. The turnover of these nucleotides is high, whereas their concentration is rather low. The de novo pathway of synthesis does not seem very efficient, although the utilization of nucleosides could represent the major pathway for pyrimidine nucleotide synthesis. In rat blood, cytidine could be the major precursor for pyrimidine nucleotide synthesis. The precursor, whatever its exact nature (uridine or cytidine), could be species dependent, and the liver could a major role in providing blood nucleosides. Owing to the essential role of pyrimidine nucleotides in the synthesis of macromolecules, acute or chronic alteration of the metabolism of these nucleotides could have crucial consequences on heart viability and function. Providing pyrimidine precursors to the heart, isolated or in situ, induces functional and metabolic effects on the heart. The experimental results suggest that such interventions could be beneficial in clinical situations such as cardioplegia, heart preservation, or recovery from ischemia.
心肌中嘧啶核苷酸的代谢目前了解甚少。这些核苷酸的周转速度很快,但其浓度却相当低。尽管核苷的利用可能是嘧啶核苷酸合成的主要途径,但从头合成途径似乎效率不高。在大鼠血液中,胞嘧啶可能是嘧啶核苷酸合成的主要前体。无论前体的确切性质如何(尿苷或胞苷),都可能因物种而异,肝脏可能在提供血液核苷方面起主要作用。由于嘧啶核苷酸在大分子合成中具有重要作用,这些核苷酸代谢的急性或慢性改变可能对心脏的生存能力和功能产生关键影响。向离体或原位心脏提供嘧啶前体,会对心脏产生功能和代谢影响。实验结果表明,这种干预措施在诸如心脏停搏、心脏保存或缺血后恢复等临床情况中可能有益。